SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640334-22-001024
Filing Date
2022-05-16
Accepted
2022-05-16 08:20:54
Documents
16
Period of Report
2022-05-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K artl_8k.htm   iXBRL 8-K 35007
2 PURCHASE AGREEMENT artl_ex101.htm EX-10.1 202461
3 REGISTRATION RIGHTS AGREEMENT artl_ex102.htm EX-10.2 86107
  Complete submission text file 0001640334-22-001024.txt   519337

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA artl-20220513.xsd EX-101.SCH 5845
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE artl-20220513_lab.xml EX-101.LAB 14731
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE artl-20220513_cal.xml EX-101.CAL 908
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE artl-20220513_pre.xml EX-101.PRE 9366
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE artl-20220513_def.xml EX-101.DEF 2113
10 EXTRACTED XBRL INSTANCE DOCUMENT artl_8k_htm.xml XML 3605
Mailing Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 858-925-7049
ARTELO BIOSCIENCES, INC. (Filer) CIK: 0001621221 (see all company filings)

IRS No.: 331220924 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38951 | Film No.: 22925668
SIC: 2834 Pharmaceutical Preparations